• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育性和癫痫性脑病:从遗传异质性到表型连续统。

Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum.

机构信息

Neuroscience Department, Meyer Children's Hospital, Florence, Italy.

University of Florence, Florence, Italy.

出版信息

Physiol Rev. 2023 Jan 1;103(1):433-513. doi: 10.1152/physrev.00063.2021. Epub 2022 Aug 11.

DOI:10.1152/physrev.00063.2021
PMID:35951482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9576177/
Abstract

Developmental and epileptic encephalopathies (DEEs) are a heterogeneous group of disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities on a background of developmental impairment that tends to worsen as a consequence of epilepsy. DEEs may result from both nongenetic and genetic etiologies. Genetic DEEs have been associated with mutations in many genes involved in different functions including cell migration, proliferation, and organization, neuronal excitability, and synapse transmission and plasticity. Functional studies performed in different animal models and clinical trials on patients have contributed to elucidate pathophysiological mechanisms underlying many DEEs and have explored the efficacy of different treatments. Here, we provide an extensive review of the phenotypic spectrum included in the DEEs and of the genetic determinants and pathophysiological mechanisms underlying these conditions. We also provide a brief overview of the most effective treatment now available and of the emerging therapeutic approaches.

摘要

发育性和癫痫性脑病(DEEs)是一组异质性疾病,其特征为早期发病、常伴有严重的癫痫发作和脑电图异常,且伴有发育障碍,这种障碍会因癫痫而恶化。DEEs 可能由遗传和非遗传病因引起。许多参与不同功能的基因的突变与遗传性 DEEs 有关,包括细胞迁移、增殖和组织、神经元兴奋性以及突触传递和可塑性。在不同的动物模型和临床试验中进行的功能研究有助于阐明许多 DEEs 的病理生理机制,并探索了不同治疗方法的疗效。在这里,我们广泛回顾了 DEEs 的表型谱以及这些疾病的遗传决定因素和病理生理机制。我们还简要概述了目前最有效的治疗方法和新兴的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22c/9576177/d766f626e98e/prv-00063-2021r01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22c/9576177/d766f626e98e/prv-00063-2021r01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22c/9576177/d766f626e98e/prv-00063-2021r01.jpg

相似文献

1
Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum.发育性和癫痫性脑病:从遗传异质性到表型连续统。
Physiol Rev. 2023 Jan 1;103(1):433-513. doi: 10.1152/physrev.00063.2021. Epub 2022 Aug 11.
2
KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.KCNT1 相关性癫痫和癫痫性脑病:表型和突变谱。
Brain. 2021 Dec 31;144(12):3635-3650. doi: 10.1093/brain/awab219.
3
Synaptopathies in Developmental and Epileptic Encephalopathies: A Focus on Pre-synaptic Dysfunction.发育性和癫痫性脑病中的突触病变:聚焦于突触前功能障碍
Front Neurol. 2022 Mar 8;13:826211. doi: 10.3389/fneur.2022.826211. eCollection 2022.
4
Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.遗传性发育及癫痫性脑病的自然病史研究和临床试验准备
Neurotherapeutics. 2021 Jul;18(3):1432-1444. doi: 10.1007/s13311-021-01133-3. Epub 2021 Oct 27.
5
Neuromodulation strategies in developmental and epileptic encephalopathies.发育性和癫痫性脑病的神经调节策略。
Epilepsy Behav. 2024 Nov;160:110067. doi: 10.1016/j.yebeh.2024.110067. Epub 2024 Oct 10.
6
The expanding field of genetic developmental and epileptic encephalopathies: current understanding and future perspectives.遗传发育性癫痫性脑病领域的拓展:当前的认识和未来的展望。
Lancet Child Adolesc Health. 2024 Nov;8(11):821-834. doi: 10.1016/S2352-4642(24)00196-2.
7
Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts.癫痫性脑病——临床综合征与病理生理概念
Curr Neurol Neurosci Rep. 2017 Feb;17(2):10. doi: 10.1007/s11910-017-0720-7.
8
[Epileptic encephalopathies of onset in neonates and infants].[新生儿及婴儿期起病的癫痫性脑病]
Medicina (B Aires). 2022 Aug 30;82 Suppl 3:13-18.
9
Unveiling the disease progression in developmental and epileptic encephalopathies: Insights from EEG and neuropsychology.揭示发育性和癫痫性脑病的疾病进展:来自 EEG 和神经心理学的见解。
Epilepsia. 2024 Nov;65(11):3279-3292. doi: 10.1111/epi.18127. Epub 2024 Sep 17.
10
Insights from Spatial Measures of Intolerance to Identifying Pathogenic Variants in Developmental and Epileptic Encephalopathies.从发育性和癫痫性脑病中识别致病性变异的不可容忍性的空间度量的见解。
Int J Mol Sci. 2023 Mar 7;24(6):5114. doi: 10.3390/ijms24065114.

引用本文的文献

1
People with epilepsy and intellectual disability.患有癫痫和智力残疾的人。
Acta Neurol Belg. 2025 Sep 15. doi: 10.1007/s13760-025-02884-y.
2
De Novo HNRNPU Pathogenic Variant Related to Developmental Epileptic Encephalopathy With Inherited KANSL1 Loss-of-Function Variant Resolved by RNA Analysis.通过RNA分析解决的与发育性癫痫性脑病相关的从头HNRNPU致病变异,伴有遗传性KANSL1功能丧失变异。
Mol Genet Genomic Med. 2025 Sep;13(9):e70127. doi: 10.1002/mgg3.70127.
3
Role of the YWHAG gene mutations in Developmental and Epileptic Encephalopathy.

本文引用的文献

1
International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions.国际抗癫痫联盟关于可变年龄起病的癫痫综合征的分类和定义:由 ILAE 分类和定义工作组发布的立场声明。
Epilepsia. 2022 Jun;63(6):1443-1474. doi: 10.1111/epi.17240. Epub 2022 May 3.
2
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.国际抗癫痫联盟儿童期起病的癫痫综合征分类和定义:ILAE 分类和定义工作组的立场文件。
Epilepsia. 2022 Jun;63(6):1398-1442. doi: 10.1111/epi.17241. Epub 2022 May 3.
3
YWHAG基因突变在发育性和癫痫性脑病中的作用。
Front Neurosci. 2025 Aug 15;19:1641250. doi: 10.3389/fnins.2025.1641250. eCollection 2025.
4
The use of synaptic extracellular myo-inositol to treat Developmental and Epileptic Encephalopathy.使用突触细胞外肌醇治疗发育性和癫痫性脑病。
Ann Child Neurol Soc. 2025 Aug 25. doi: 10.1002/cns3.70029.
5
Microglial activation is inhibited by selective anti-seizure medications.小胶质细胞的激活受到选择性抗癫痫药物的抑制。
Inflamm Res. 2025 Aug 23;74(1):112. doi: 10.1007/s00011-025-02076-7.
6
The Clinical and Genetic Landscape of a French Multicenter Cohort of 2563 Epilepsy Patients Referred for Genetic Diagnosis.一个由2563名因基因诊断而转诊的癫痫患者组成的法国多中心队列的临床和遗传概况。
Eur J Neurol. 2025 Aug;32(8):e70324. doi: 10.1111/ene.70324.
7
Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice.抗癫痫药物的不良反应:药物遗传学和药物相互作用在临床实践中的影响综述
Front Pharmacol. 2025 Jul 10;16:1584566. doi: 10.3389/fphar.2025.1584566. eCollection 2025.
8
Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy.儿童癫痫中大麻素系统的失调:从机制到治疗
Int J Mol Sci. 2025 Jun 27;26(13):6234. doi: 10.3390/ijms26136234.
9
Neurodevelopmental disorders and gut-brain interactions: exploring the therapeutic potential of pycnogenol through microbial-metabolic-neural networks.神经发育障碍与肠-脑相互作用:通过微生物-代谢-神经网络探索碧萝芷的治疗潜力。
Front Cell Infect Microbiol. 2025 Jun 11;15:1601888. doi: 10.3389/fcimb.2025.1601888. eCollection 2025.
10
Clinical and functional characterization of the GABRB3 p.Met80Val variant in early-onset epilepsy with long-term follow-up.早发性癫痫中GABRB3基因p.Met80Val变异体的临床及功能特征:长期随访研究
Ital J Pediatr. 2025 Jun 20;51(1):195. doi: 10.1186/s13052-025-02046-z.
ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions.
ILAE 新生儿和婴儿起病的癫痫综合征分类和定义:ILAE 分类和术语定义特别工作组的立场声明。
Epilepsia. 2022 Jun;63(6):1349-1397. doi: 10.1111/epi.17239. Epub 2022 May 3.
4
Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model.反义寡核苷酸疗法可减少癫痫发作并延长 SCN2A 功能获得性癫痫模型的寿命。
J Clin Invest. 2021 Dec 1;131(23). doi: 10.1172/JCI152079.
5
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy.单靶点药物与多靶点药物以及多靶点药物组合:治疗或预防癫痫的临床前和临床证据
Front Pharmacol. 2021 Oct 27;12:730257. doi: 10.3389/fphar.2021.730257. eCollection 2021.
6
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome.芬氟拉明对 Dravet 综合征患者预期性 SUDEP 死亡率的影响。
Seizure. 2021 Dec;93:154-159. doi: 10.1016/j.seizure.2021.10.024. Epub 2021 Nov 2.
7
Persistent sodium currents in developmental and degenerative epileptic dyskinetic encephalopathy.发育性和退行性癫痫性运动障碍性脑病中的持续性钠电流
Brain Commun. 2021 Oct 7;3(4):fcab235. doi: 10.1093/braincomms/fcab235. eCollection 2021.
8
Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome.中链甘油三酯饮食对 Dravet 综合征小鼠模型的保护作用。
Epilepsia. 2021 Dec;62(12):3131-3142. doi: 10.1111/epi.17101. Epub 2021 Oct 28.
9
Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies.基于诱导多能干细胞的神经系统中的基因组编辑:从疾病模型到未来治疗策略
Front Genome Ed. 2021 Mar 15;3:630600. doi: 10.3389/fgeed.2021.630600. eCollection 2021.
10
Fenfluramine significantly reduces day-to-day seizure burden by increasing number of seizure-free days and time between seizures in patients with Dravet syndrome: A time-to-event analysis.芬氟拉明可显著增加 Dravet 综合征患者无癫痫发作天数和癫痫发作间隔时间,从而降低日常癫痫发作负担:一项基于时间的分析。
Epilepsia. 2022 Jan;63(1):130-138. doi: 10.1111/epi.17106. Epub 2021 Oct 22.